Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Neoplasms

Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Colorectal Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Triple Negative Breast Neoplasms

Solid Tumor, Adult

Astrocytoma, Glioma

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms, Recurrence

Colorectal Neoplasms

Hyperthermia, Digestive System Neoplasms

Colorectal Neoplasms

Metastatic Colorectal Adenocarcinoma

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Cholangiocarcinoma

Lung Neoplasms

Arthritis, Autoimmune Diseases, Endocrine System Diseases, Eye Diseases, Heart Diseases, Myositis, Neoplasms

Clinical Trials

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Priming Immunotherapy in Advanced Disease With Radiation

CIML NK Cell in Head & Neck Cancer

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

PRIMM

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy

PLATINUM

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

AUTENTIC

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

CLASSIC5

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

EXIT

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

HEAIS001

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Postoperative Adjuvant Therapy of HCC Based on PD-1

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

CHIMeRA

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma